Dell'Osso B

Department of Mental Health and Addiction Services, ASST Fatebenefratelli-Sacco, Milan, 20157, Italy.

14 papers · 1 preprint · ORCID

ArticleKetamine

Ketamine and esketamine during breastfeeding: a systematic review of human pharmacokinetic, infant and lactation outcomes.

Olivola M, Martiadis V, Prodi T +6

Europe PMC2026
ArticleKetamine

Esketamine-based treatment, depression-specific metacognitive training, and their combination in treatment-resistant depression: 6-month trajectories of depressive symptoms and rumination in a multicenter observational study.

Martiadis V, Raffone F, Atripaldi D +8

Europe PMC2026
ArticleKetamine

Suicidal ideation covaries with depressive severity during six-month real-world esketamine treatment in a cohort enriched for borderline personality disorder.

Martiadis V, Raffone F, Mazzoni F +6

Europe PMC2026
ArticleKetamine

Intranasal esketamine in treatment-resistant depression with and without comorbid borderline personality disorder: A multicenter real-world longitudinal study.

Mazzoni F, Raffone F, De Ciechi A +6

Europe PMC2026
ArticleKetamine

Esketamine in treatment-resistant depression with and without comorbid borderline personality disorder: A real-world longitudinal study of suicidal ideation and self-harm.

Raffone F, Mazzoni F, De Ciechi A +6

Europe PMC2026
ArticleKetamine

Cognitive Effects of Esketamine in Treatment-Resistant Depression: A Systematic Review.

Guglielmo R, Facchinetti EL, Cioci D +6

Europe PMC2026
ArticleKetamine

Efficacy and Safety of Intranasal Esketamine in Treatment-Resistant Depression with Comorbid Autism Spectrum Disorder: Three Case Reports.

Guffanti A, Leonardi M, Brondino N +3

Europe PMC2026
ArticleKetamine

Narrative Experiences of Esketamine-Induced Dissociation in Patients with Treatment-Resistant Depression: A Qualitative Exploratory Study.

Olivola M, Prodi T, Versaci G +9

Europe PMC2026
ArticleKetamine

Personalizing esketamine treatment in TRD and TRBD: the role of mentalization, cognitive rigidity, psychache, and suicidality.

Olivola M, Mazzoni F, Tarantino B +12

Europe PMC2025
PreprintKetamine

Efficacy and Safety of Intranasal Esketamine in Treatment-Resistant Depression with Comorbid Autism Spectrum Disorder: Three Case Reports

Guffanti A, Leonardi M, Brondino N +3

Europe PMC2026
ArticleKetamine

Mentalization and Emotional-Cognitive Rigidity as predictors of esketamine's effects on Treatment-Resistant Depression: Findings from a prospective observational study.

Olivola M, Mazzoni F, Tarantino B +11

Europe PMC2026
ArticleKetamine

Patient Experience with Intranasal Esketamine in Treatment-Resistant Depression: Insights from a Multicentric Italian Study (REAL-ESKperience).

Di Nicola M, Pepe M, d'Andrea G +26

Europe PMC2025
ArticleKetamine

Exploring the potential of Esketamine in the treatment of bipolar depression.

Dell'Osso B, Martinotti G

Europe PMC2023
ArticleKetamine

Esketamine in treatment-resistant depression patients comorbid with substance-use disorder: A viewpoint on its safety and effectiveness in a subsample of patients from the REAL-ESK study.

Chiappini S, d'Andrea G, De Filippis S +10

Europe PMC2023
ArticleKetamine

Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment-resistant depression.

Martinotti G, Dell'Osso B, Di Lorenzo G +23

Europe PMC2023